These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17714552)
1. A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst. Royer JF; Schratl P; Lorenz S; Kostenis E; Ulven T; Schuligoi R; Peskar BA; Heinemann A Allergy; 2007 Dec; 62(12):1401-9. PubMed ID: 17714552 [TBL] [Abstract][Full Text] [Related]
2. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884 [TBL] [Abstract][Full Text] [Related]
4. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. Schratl P; Royer JF; Kostenis E; Ulven T; Sturm EM; Waldhoer M; Hoefler G; Schuligoi R; Lippe IT; Peskar BA; Heinemann A J Immunol; 2007 Oct; 179(7):4792-9. PubMed ID: 17878378 [TBL] [Abstract][Full Text] [Related]
5. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. Böhm E; Sturm GJ; Weiglhofer I; Sandig H; Shichijo M; McNamee A; Pease JE; Kollroser M; Peskar BA; Heinemann A J Biol Chem; 2004 Feb; 279(9):7663-70. PubMed ID: 14668348 [TBL] [Abstract][Full Text] [Related]
6. Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. Heinemann A; Schuligoi R; Sabroe I; Hartnell A; Peskar BA J Immunol; 2003 May; 170(9):4752-8. PubMed ID: 12707356 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2. Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001 [TBL] [Abstract][Full Text] [Related]
8. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. Gervais FG; Cruz RP; Chateauneuf A; Gale S; Sawyer N; Nantel F; Metters KM; O'neill GP J Allergy Clin Immunol; 2001 Dec; 108(6):982-8. PubMed ID: 11742277 [TBL] [Abstract][Full Text] [Related]
9. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. Chevalier E; Stock J; Fisher T; Dupont M; Fric M; Fargeau H; Leport M; Soler S; Fabien S; Pruniaux MP; Fink M; Bertrand CP; McNeish J; Li B J Immunol; 2005 Aug; 175(4):2056-60. PubMed ID: 16081770 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101 [TBL] [Abstract][Full Text] [Related]
11. Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma. Issahaku AR; Agoni C; Soremekun OS; Kubi PA; Kumi RO; Olotu FA; Soliman MES Comb Chem High Throughput Screen; 2019; 22(8):521-533. PubMed ID: 31538888 [TBL] [Abstract][Full Text] [Related]
12. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751 [TBL] [Abstract][Full Text] [Related]
13. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. Sugimoto H; Shichijo M; Iino T; Manabe Y; Watanabe A; Shimazaki M; Gantner F; Bacon KB J Pharmacol Exp Ther; 2003 Apr; 305(1):347-52. PubMed ID: 12649388 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). Liu F; Gonzalo JA; Manning S; O'Connell LE; Fedyk ER; Burke KE; Elder AM; Pulido JC; Cao W; Tayber O; Qiu Y; Ghosh S; Ocain TD; Hodge MR; Suzuki-Yagawa Y Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):133-47. PubMed ID: 15967168 [TBL] [Abstract][Full Text] [Related]
15. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971 [TBL] [Abstract][Full Text] [Related]
16. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. El-Shazly AE; Moonen V; Mawet M; Begon D; Henket M; Arafa M; Louis R; Delvenne P; Lefebvre PP Int Immunopharmacol; 2011 Nov; 11(11):1864-70. PubMed ID: 21835268 [TBL] [Abstract][Full Text] [Related]
17. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313 [TBL] [Abstract][Full Text] [Related]
18. Antagonists of the prostaglandin D2 receptor CRTH2. Pettipher R; Hansel TT Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589 [TBL] [Abstract][Full Text] [Related]
19. 15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. Hatanaka M; Shibata N; Shintani N; Haba R; Hayata A; Hashimoto H; Baba A J Pharmacol Sci; 2010; 113(1):89-93. PubMed ID: 20424389 [TBL] [Abstract][Full Text] [Related]
20. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]